AXTA vs BIIB · P/E 15, rev $5.12B vs P/E 21, rev $9.89B
Axalta Coating Systems Ltd (AXTA) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
Axalta Coating Systems Ltd (AXTA) is a specialty chemicals company listed on US.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Latest reported AXTA revenue for 2025-12-31 was $5.12B. Net income was $378.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. AXTA currently screens at market cap $6.76B and trailing P/E 15.1.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
AXTA currently screens at market cap $6.76B and trailing P/E 15.1. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the AXTA and BIIB stock pages for the full models.
Not investment advice.